1.北京中医药大学东直门医院血液肿瘤科,北京 100700
2.中国中医科学院西苑医院血液科,北京 100091
吴洁雅,女,27岁,博士。研究方向:中西医结合防治血液病。
侯丽,E-mail: houli1203@126.com
扫 描 看 全 文
吴洁雅,王婧,马薇,等.骨髓增生异常综合征患者IPSS-R与中医证型、症状的相关性[J].北京中医药,2023,42(11):1197-1203.
WU Jie-ya,WANG Jing,MA Wei,et al.Correlation between IPSS-R and TCM syndromes and symptoms in patients with myelodysplastic syndrome[J]. Beijing Journal of Traditional Chinese Medicine,2023,42(11):1197-1203.
吴洁雅,王婧,马薇,等.骨髓增生异常综合征患者IPSS-R与中医证型、症状的相关性[J].北京中医药,2023,42(11):1197-1203. DOI: 10.16025/j.1674-1307.2023.11.008.
WU Jie-ya,WANG Jing,MA Wei,et al.Correlation between IPSS-R and TCM syndromes and symptoms in patients with myelodysplastic syndrome[J]. Beijing Journal of Traditional Chinese Medicine,2023,42(11):1197-1203. DOI: 10.16025/j.1674-1307.2023.11.008.
目的,2,探讨骨髓增生异常综合征(myelodysplastic syndromes,MDS)的修订版国际预后积分系统(IPSS-revised,IPSS-R)与中医证型及症状的相关性。,方法,2,选择2016年1月1日—2021年9月30日北京中医药大学东直门医院血液肿瘤科收治的80例MDS住院患者,对IPSS-R指标(血红蛋白水平、中性粒细胞水平、血小板水平、骨髓原始细胞百分比、细胞遗传学)及中医证型(正虚证型、邪实证型)和舌象临床数据进行分析,明确其相关性。并对其中32例患者进行中医症状分级与IPSS-R积分的相关性分析。,结果,2,IPSS-R与中医证型分布方面,不同IPSS-R患者正虚均以气血两虚证、气阴两虚证为主,然而中危+高危+极高危患者相比极低危+低危患者,脾肾阳虚比例大幅上升。舌质方面,随着IPSS-R积分增加,淡红舌比例下降,其他舌质(包括淡白、淡紫、红舌)比例上升。血细胞减少与中医证型分布方面,单系血细胞减少的患者以气血两虚、气阴两虚为主(分别占12/33和10/33),双系、三系血细胞减少的患者脾肾阳虚证型比例较单系血细胞减少增加。在单系血细胞减少患者中,血红蛋白减少者以“无”邪实为主(9/21),而血小板减少者邪实以“瘀”为主(6/11)。IPSS-R与中医症状分级相关性方面,疲乏分级与IPSS-R呈正相关,与血红蛋白水平呈负相关;瘀斑分级、出血分级与血小板水平呈负相关。,结论,2,脾肾阳虚证与IPSS-R积分升高、多系血细胞减少、骨髓原始细胞增多可能存在相关性;在单系血细胞减少患者中,血红蛋白减少可能与虚证有相关性,而“瘀”可能与血小板减少存在相关性。
Objective,2,To explore the correlation between traditional Chinese medicine (TCM) syndromes and symptoms and the revised International Prognostic Score System(IPSS-R) in patients with myelodysplastic syndrome (MDS).,Methods,2,The clinical data of 80 MDS patients, who were hospitalized in the Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicinefrom1 Junuary 2016 to 30 September 2021, were collected. The data of IPSS-R (hemoglobin levels, neutrophil levels, platelet levels, bone marrow blast percentages, cytogenetic results) and TCM syndromes (syndrome of antipathogenic qi deficiency and syndrome of excessive pathogenic factors)with tongue manifestations were analyzed to clarify their correlation. The correlation between IPSS-R and TCM symptoms grading of 32 out of 80 MDS patients were also investigated.,Results,2,By analyzing the correlation between the distribution of IPSS-R score and TCM syndromes,deficiency of antipathogenic qi mainly included deficiency of blood and qi and deficiency of qi and yin, however, compared with extremely low risk+low risk, the proportion of spleen and kidney yang deficiency in patients with moderate risk+high risk+extremely high risk has increased significantly.In terms of tongue body,with the increase of IPSS-R score,the proportion of pale red tongue decreased, and the proportion of other tongue manifestations (including pale white, pale purple and red tongue) increased. The results of hematocytopenia and TCM syndrome distribution showed that the patients with hematocytopenia of one lineage were mainly characterized by deficiency of both qi and blood and deficiency of both qi and yin (12/33 and 10/33,respectively). Among the patients with hematocytopenia of two lineages and three lineages, the proportion of spleen and kidney yang deficiency was higher than that of one lineage hematocytopenia. In patients who had one lineage hematocytopenia,“none” excessive pathogenic factors was the main syndrome among anemia patients (9/21), while blood stasis was the main one among thrombocytopenia patients (6/11). The results of correlation analysis between IPSS-R and TCM symptoms showed that fatigue grading was positively related with IPSS-R and negatively related with hemoglobin levels. The ecchymosis hemorrhage grading was negatively related with the levels of platelet;the grading of ecchymosis and hemorrhage was negatively correlated with platelet level.,Conclusion,2,The syndrome of spleen and kidney yang deficiency may be related with the increase of IPSS-R score,multilineage cytopenia and bone marrow primordial cells.Among patients of one lineage hematocytopenia,the decrease of hemoglobin may be related to deficiency syndrome, while blood stasis may be related with neutropenia.
骨髓增生异常综合征修订版国际预后积分系统中医证型中医症状
Myelodysplastic syndromesIPSS-RTCM syndromesTCM symptoms
ZEIDAN AM, SHALLIS RM, WANG R, et al. Epidemiology of myelodysplastic syndromes: Why characterizing the beast is a prerequisite to taming it[J]. Blood Rev, 2019,34:1-15.
GREENBERG PL, TUECHLER H, SCHANZ J, et al. Revised international prognostic scoring system for myelodysplastic syndromes[J]. Blood,2012,120(12):2454-2465.
ARBER DA, ORAZI A, HASSERJIAN R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia[J]. Blood, 2016,127(20):2391-2405.
National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program: All cancer sites combined: recent trends in SEER age-adjusted incidence rates, 2000-2019 by sex, delay-adjusted SEER incidence rate, all races, all ages [DB/OL]. [2022-06-22]. http://www.seer.cancer.govhttp://www.seer.cancer.gov.
CARRAWAY HE, SAYGIN C. Therapy for lower-risk MDS[J]. Hematology Am Soc Hematol Educ Program, 2020(1):426-433.
陆嘉惠. 中医药防治骨髓增生异常综合征研究述评[J]. 北京中医药大学学报,2022,45(3):217-222.
陈信义, 张雅月, 郎海燕,等. 中医药防治急性髓细胞性白血病一体化研究述评[J]. 北京中医药,2021,40(5):446-450.
李蕊白, 潘一鸣, 吴洁雅,等. 益髓颗粒对低危、中危Ⅰ型骨髓增生异常综合征患者贫血及相关症状的改善作用[J]. 北京中医药,2021,40(5):456-460.
EFFICACE F, COTTONE F, OSWALD LB, et al. The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index[J]. Leukemia, 2020,34(9):2451-2459.
中华医学会血液学分会. 骨髓增生异常综合征中国诊断与治疗指南(2019年版)[J]. 中华血液学杂志,2019,40(2):89-97.
LOUISE DS, ALEX S, THOMAS WJ, et al. Validation of the revised international prognostic scoring system (IPSS-R) in patients with lower-risk myelodysplastic syndromes: a report from the prospective European LeukaemiaNet MDS (EUMDS) registry[J]. Br J Haematol, 2015,170(3):372-383.
中国中西医结合学会血液学专业委员会骨髓增生异常综合征专家委员会. 骨髓增生异常综合征中西医结合诊疗专家共识(2018年)[J]. 中国中西医结合杂志,2018,38(8):914-920.
HONG M, HE G. The 2016 revision to the World Health Organization classification of myelodysplastic syndromes[J]. J Transl Int Med, 2017,5(3):139-143.
李灿东,方朝义.中医诊断学[M].北京:中国中医药出版社,2021:89-121,285-306.
郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.
REEVE BB,STOVER AM,ALFANO CM, et al. The Piper Fatigue Scale-12 (PFS-12): psychometric findings and item reduction in a cohort of breast cancer survivors[J]. Breast Cancer Res Treat, 2012,136(1):9-20.
JIANG Y, EVEILLARD JR, COUTURIER MA, et al. Asian population is more prone to develop high-risk myelodysplastic syndrome, concordantly with their propensity to exhibit high-risk cytogenetic aberrations[J]. Cancers (Basel), 2021,13(3):481.
AL-KALI A, ZBLEWSKI D, FORAN JM, et al. Outcome of myelodysplastic syndromes over time in the united states: a national cancer data base study from 2004-2013[J]. Mayo Clin Proc, 2019,94(8):1467-1474.
刘晓娟,顾任钧,孙雪梅.基于现代文献分析骨髓增生异常综合征的中医证型分布及用药规律[J].世界中西医结合杂志,2020,15(10):1797-1800,1845.
段赟,夏小军,崔杰,等.试述中医辨治骨髓增生异常综合征的切入点与策略[J].中医临床研究,2019,11(33):6-7.
WANG D, XU Y, DU Y, et al. Arsenic concentration in peripheral blood is correlated with efficacy of a traditional Chinese medicine regimen containing realgar for the treatment of myelodysplastic syndromes[J]. J Tradit Chin Med, 2021,41(4):630-635.
王德秀, 麻柔, 杜宇,等. 青黄散方案治疗骨髓增生异常综合征伴多系病态造血疗效及血砷浓度观察[J]. 中国中西医结合杂志,2021,41(9):1068-1072.
陈娇健,王立森.黄金昶刺血拔罐治疗化疗相关性血小板减少症经验[J].湖北中医杂志,2023,45(7):25-29.
向郭华,杨茜茹,许晶,等.基于《内经》“调平”诸法治疗免疫性血小板减少症[J].环球中医药,2023,16(8):1605-1608.
AMITAI I, GEDDES M, ZHU N, et al. Fatigue, however measured, continues to refine prognosis in higher risk MDS: An MDS-CAN study[J]. Blood,2020,136:41-43.
PROCHASKA MT, NEWCOMB R, BLOCK G, et al. Association between anemia and fatigue in hospitalized patients: does the measure of anemia matter[J]. J Hosp Med, 2017,12(11):898-904.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构